Cargando…

Biphosphonates-associated osteonecrosis of the jaw: the role of gene-environment interaction

Biphosphonate (BPN) are widely used in clinics to treat metastatic cancer and osteoporosis thus representing a problem not only for patients but also for workers involved in their preparation and administration. A similar exposure occurred years ago in match-making workers undergoing bone alteration...

Descripción completa

Detalles Bibliográficos
Autores principales:	IZZOTTI, A., MENINI, M., PULLIERO, A., DINI, G., CARTIGLIA, C., PERA, P., BALDI, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718369/ https://www.ncbi.nlm.nih.gov/pubmed/24783891

Ejemplares similares

Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations
por: Borgioli, Alberto, et al.
Publicado: (2009)

Biomarkers to predict the onset of biphosphonate-related osteonecrosis of the jaw: A systematic review
por: Lorenzo-Pouso, Alejandro I., et al.
Publicado: (2019)

Post biphosphonate mandible osteonecrosis: A case study and literature review
por: Aboubacar, Bambara H., et al.
Publicado: (2023)

New antirheumatic effects of biphosphonate treatment
por: Konenkova, L, et al.
Publicado: (2001)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role
por: Capsoni, Franco, et al.
Publicado: (2006)

Prediction of Titanium Implant Success by Analysis of microRNA Expression in Peri-Implant Tissue. A 5-Year Follow-Up Study
por: Menini, Maria, et al.
Publicado: (2019)

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012)

Special Issue: “Role of MicroRNA in Cancer Development and Treatment”
por: Pulliero, Alessandra, et al.
Publicado: (2022)

Bisphophonates related osteonecrosis of the jaw
por: Gupta, Swati, et al.
Publicado: (2013)

RANK-Ligand inhibitor associated osteonecrosis of the jaw
por: Rashad, Ashkan, et al.
Publicado: (2013)

Role of Periapical Diseases in Medication-Related Osteonecrosis of the Jaws
por: Rao, Nian Jing, et al.
Publicado: (2017)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

The Role of Geranylgeraniol in Managing Bisphosphonate-Related Osteonecrosis of the Jaw
por: Chin, Kok-Yong, et al.
Publicado: (2022)

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016)

Anatomical factors in medication-related osteonecrosis of the jaws
por: Correia, J. A., et al.
Publicado: (2021)

Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013)

Osteonecrosis of the jaws in patients treated with bisphosphonates
por: Ata-Ali, Fadi, et al.
Publicado: (2012)

Bisphosphonate-Related Osteonecrosis of the Jaw: Specificities
por: Paulo, Siri, et al.
Publicado: (2014)

Expert opinion about osteonecrosis of the jaw
por: Lee, Jeong Keun
Publicado: (2017)

Outcomes of Clinical Trials on Osteonecrosis of the Jaw
por: Wu, Brendan W, et al.
Publicado: (2021)

Medication-related osteonecrosis of the jaw: An update
por: Bansal, Hitesh
Publicado: (2022)

The impact of sex steroids on osteonecrosis of the jaw
por: Kim, Ranhee, et al.
Publicado: (2022)

Update on Medication Related Osteonecrosis of the Jaws
por: Boyd, Barry C.
Publicado: (2023)

Perimandibular abscess associated with bisphosphonate‐related osteonecrosis of the jaw
por: Ocho, Kazuki, et al.
Publicado: (2017)

Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
por: Lundberg, A.P., et al.
Publicado: (2016)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)()
por: Baba, Akira, et al.
Publicado: (2019)

Alendronate-associated osteonecrosis of the jaws: A review of the main topics
por: Paiva-Fonseca, Felipe, et al.
Publicado: (2014)

Bisphosphonate-related osteonecrosis of the jaw and dental implants
por: Qamheya, Ala Hassan A., et al.
Publicado: (2016)

The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw
por: Zhang, Weidong, et al.
Publicado: (2021)

Medication-related Osteonecrosis of the Jaw: A Review
por: AlDhalaan, Nouf A, et al.
Publicado: (2020)

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients
por: Walter, Christian, et al.
Publicado: (2010)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication)()
por: Tsuchimochi, Makoto, et al.
Publicado: (2019)

Evolution and Etiopathogenesis of Bisphosphonates Induced Osteonecrosis of the Jaw
por: Kumar, Vijay, et al.
Publicado: (2013)

Bisphosphonates and Osteonecrosis of the Jaw: A Case Report
por: Reiriz, André Borba, et al.
Publicado: (2008)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Imaging findings in bisphosphonate-induced osteonecrosis of the jaws
por: Popovic, Katarina Surlan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ctu47k68n8pm8a47b1tqqtsq4l